Abstract:Extracellular vesicles (EVs) are identified as mediators of intercellular communication and cellular regulation. In the immune system, EVs play a role in antigen presentation as a part of cellular communication. To enable drug discovery and characterization of compounds that affect EV biogenesis, function, and release in immune cells, we developed and characterized a reporter cell line that allows the quantitation of EVs shed into culture media in phenotypic high-throughput screen (HTS) format. Tetraspanins CD63 and CD9 were previously reported to be enriched in EVs; hence, a construct with dual reporters consisting of CD63-Turbo-luciferase (Tluc) and CD9-Emerald green fluorescent protein (EmGFP) was engineered. This construct was transduced into the human monocytic leukemia cell line, THP-1. Cells expressing the highest EmGFP were sorted by flow cytometry as single cell, and clonal pools were expanded under antibiotic selection pressure. After four passages, the green fluorescence dimmed, and EV biogenesis was then tracked by luciferase activity in culture supernatants. The Tluc activities of EVs shed from CD63Tluc-CD9EmGFP reporter cells in the culture supernatant positively correlated with the concentrations of released EVs measured by nanoparticle tracking analysis. To examine the potential for use in HTS, we first miniaturized the assay into a robotic 384-well plate format. A 2210 commercial compound library (Maybridge) was then screened twice on separate days, for the induction of extracellular luciferase activity. The screening data showed high reproducibility on days 1 and 2 (78.6%), a wide signal window, and an excellent Z′ factor (average of 2-day screen, 0.54). One hundred eighty-seven compounds showed a response ratio that was 3SD above the negative controls in both day 1 and 2 screens and were considered as hit candidates (approximately 10%). Twenty-two out of 40 re-tested compounds were validated. These results indicate that the performance of CD63Tluc-CD9EmGFP reporter cells is reliable, reproducible, robust, and feasible for HTS of compounds that regulate EV release by the immune cells.

A Single-Cell Translocation And Secretion Assay (Transsea)

A Single Cell Assay for Quantifying Extracellular Vesicles from Single Cells

A Single-Cell Assay for Time Lapse Studies of Exosome Secretion and Cell Behaviors.

Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

A Self-Confined Single-Cell Loading Platform Combining PDMS Mesh and Patterned Cytop for Non-invasive Studies of Single Cell Secretions.

SEVtras delineates small extracellular vesicles at droplet resolution from single-cell transcriptomes

Linking single-cell transcriptomes with secretion using secretion-encoded single-cell sequencing (SEC-seq)

Single extracellular vesicle research: From cell population to a single cell

Multiplexed Profiling of Single-Cell Extracellular Vesicles Secretion.

High-throughput secretomic analysis of single cells to assess functional cellular heterogeneity.

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Time-resolved assessment of single-cell protein secretion by sequencing

A Single Extracellular Vesicle (EV) Flow Cytometry Approach to Reveal EV Heterogeneity

Single-Cell Secretion Analysis via Microfluidic Cell Membrane Immunosorbent Assay for Immune Profiling

Transcriptomic Features in a Single Extracellular Vesicle Via Single‐Cell RNA Sequencing

Single-Cell Cloning of Breast Cancer Cells Secreting Specific Subsets of Extracellular Vesicles

Multi‐Phenotypic Exosome Secretion Profiling Microfluidic Platform for Exploring Single‐Cell Heterogeneity

Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release

Associating growth factor secretions and transcriptomes of single cells in nanovials using SEC-seq

High-Throughput Single-Cell Extracellular Vesicle Secretion Analysis on a Desktop Scanner without Cell Counting

Point‐of‐care Multiplexed Single‐cell Protein Secretion Analysis Based on Tyramide Signal Amplification